Payments to Acquire Property, Plant, and Equipment of Anika Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Anika Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Anika Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $2,824,000, a 56% increase year-over-year.
  • Anika Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $6,826,000, a 12% decline from 2024.
  • Anika Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $7,734,000, a 43% increase from 2023.
  • Anika Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $5,427,000, a 28% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Anika Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,826,000 -$908,000 -12% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $7,734,000 +$2,307,000 +43% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $5,427,000 -$2,059,000 -28% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY
2022 $7,486,000 +$2,343,000 +46% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $5,143,000 +$3,515,000 +216% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2024 2023 FY
2020 $1,628,000 -$1,199,000 -42% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023 2022 FY
2019 $2,827,000 -$1,829,000 -39% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2022 2021 FY
2018 $4,656,000 -$4,324,000 -48% 01 Jan 2018 31 Dec 2018 10-K/A 26 Apr 2021 2020 FY
2017 $8,980,000 -$5,034,000 -36% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2020 2019 FY
2016 $14,014,000 +$4,789,000 +52% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $9,225,000 +$7,672,000 +494% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $1,553,000 +$1,112,000 +252% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $441,000 -$1,063,707 -71% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $1,504,707 +$104,359 +7.5% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $1,400,348 -$1,384,629 -50% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $2,784,977 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013 2012 FY

Anika Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,824,000 +$1,016,000 +56% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $1,808,000 +$419,000 +30% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $1,389,000 +$63,000 +4.8% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $1,326,000 +$909,000 +218% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $417,000 -$306,000 -42% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $723,000 -$307,000 -30% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $1,030,000 -$1,513,000 -59% 01 Jan 2019 31 Mar 2019 10-Q 22 May 2020 2020 Q1
Q1 2018 $2,543,000 +$868,000 +52% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $1,675,000 -$4,743,000 -74% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $6,418,000 +$6,162,000 +2407% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $256,000 -$20,513 -7.4% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016 2016 Q1
Q1 2014 $276,513 +$240,711 +672% 01 Jan 2014 31 Mar 2014 10-Q 04 May 2015 2015 Q1
Q1 2013 $35,802 -$188,257 -84% 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
Q1 2012 $224,059 +$147,489 +193% 01 Jan 2012 31 Mar 2012 10-Q 06 May 2013 2013 Q1
Q1 2011 $76,570 01 Jan 2011 31 Mar 2011 10-Q 07 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.